Blood lead levels and childhood asthma

Ahmed Abdullah Mohammed1, Faisal Yosef Mohamed, El-Sayed El-Okda

  • 1Departments of Pediatrics and *Community medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt. Correspondence to: Dr Ahmed Abdullah Mohammed, Assistant Professor of Pediatrics, Ain Shams University, Faculty of Medicine, Abbassia, Cairo Egypt. PO Box 11566. ahmedazrak@gmail.com.

Indian Pediatrics
|May 2, 2015
PubMed

Insights

Elevated blood lead levels in children are not linked to asthma diagnosis but may worsen asthma severity. Higher lead levels correlated with increased eosinophilia and immunoglobulin E, indicating a potential link to more severe allergic responses in asthmatic children.

Area of Science:

  • Environmental Health
  • Pediatric Allergy
  • Toxicology

Background:

  • Bronchial asthma is a common chronic respiratory disease in children.
  • Environmental factors, including lead exposure, are increasingly investigated for their role in asthma pathogenesis.
  • Understanding the relationship between blood lead levels and asthma severity is crucial for public health initiatives.

Purpose of the Study:

  • To measure blood lead levels in children aged 5-14 years diagnosed with bronchial asthma.
  • To investigate the correlation between blood lead levels and the severity of asthma in affected children.
  • To compare blood lead levels in asthmatic children with those in healthy controls.

Main Methods:

  • A cross-sectional analytical study was conducted at a Pediatric Allergy and Immunology Clinic in Cairo, Egypt.
  • Blood lead levels were measured using the atomic absorption spectrophotometer technique.
  • 200 children with bronchial asthma and 125 healthy controls were enrolled.

Main Results:

  • No significant difference in mean blood lead levels was found between asthmatic children and controls.
  • A high prevalence of elevated blood lead levels (>10 ug/dL) was observed in both groups (58.5% overall).
  • Elevated blood lead levels were associated with higher frequencies of eosinophilia, increased total immunoglobulin E, and greater asthma severity.

Conclusions:

  • Blood lead levels are not significantly associated with the diagnosis of asthma.
  • Elevated blood lead levels appear to be linked to increased asthma severity.
  • Higher blood lead levels correlate with increased eosinophilia and immunoglobulin E levels in asthmatic children.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.7K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
5.0K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.4K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.3K